BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Colon and Rectal Cancer
NCI Information
Clinical Trials
Colon Cancer Trials
Rectal Cancer Trials
Our Treatment Approach
Support Groups
Inherited Colorectal Cancer and Familial Polyposis Registry
Effects of Treatment
Assess Your Risk
Patient Stories
Videos and Podcasts
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
201107017
Principal Investigator:
Tan, Benjamin
Title:
A Phase I Dose-Escalation Trial of Biweekly Intraperitoneal Oxaliplatin with Systemic Capecitabine and Bevacizumab Following Cytoreduction in Patients with Peritoneal Carcinomatosis from Appendiceal or Colorectal Cancer
Phase:
I
Disease Site:
Multiple Sites
Participating Site(s):
Main Campus
Map and Directions
South County
Map and Directions
West County
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The main purpose of this research is to evaluate an intraperitoneal treatment for cancer following a surgical attempt to remove as much or all of the cancer as possible. The goals of this study are to determine the safety and side effects of this treatment, and to learn the maximum tolerated dose (the highest dose of a drug or treatment that does not cause unacceptable side effects) of oxaliplatin following surgery when used in combination with the other two drugs.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)